Featured image for “Tonia Sylvester: Why She Fights”
01/23/2020

Tonia Sylvester: Why She Fights

…the medical team noticed a cluster of tiny little brown spots on her lower leg, which is referred to as…
Blog - Melanoma360
Survivor Stories
Featured image for “Interview with Allison Betof Warner, MD, PhD: TIL Therapy”
04/11/2024

Interview with Allison Betof Warner, MD, PhD: TIL Therapy

…types of melanoma? Acral, mucosal, cutaneous, and melanoma of unknown primary origin are approved. These types of melanoma were included…
Blog - Melanoma360
Melanoma Research
Featured image for “In Plain English: Options for Stage III Melanoma”
06/11/2019

In Plain English: Options for Stage III Melanoma

…III melanoma is considered high-risk—meaning it has a high likelihood of recurring or spreading. In fact, patients with Stage III…
Blog - Melanoma360
In Plain English
Featured image for “In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses”
01/10/2021

In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses

  By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
Blog - Melanoma360
In Plain English
Featured image for “A Melanoma Story of Sisters, Love, and Healing”
05/12/2021

A Melanoma Story of Sisters, Love, and Healing

…her sister’s life interrupted, in 2010, Alice Googled “melanoma” and the results of the search turned up AIM at Melanoma’s…
Blog - Melanoma360
Friends, Family, & Caregivers
Featured image for “USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma”
09/20/2021

USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

…treated metastatic melanoma; Checkmate 066–previously untreated metastatic melanoma; Checkmate 067–previously untreated metastatic melanoma, as a single agent or in combination…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “President’s Letter | September 2022”
09/27/2022

President’s Letter | September 2022

…survivor stories: Please meet Erich Djordjevic and Bev Johnson. Erich is a Stage IV brain mets survivor, and Bev is…
Blog - Melanoma360
President's Letter
Featured image for “AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center”
04/04/2019

AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center

…are welcome to query Alicia Rowell, Vice President, AIM at Melanoma Foundation (Alicia@AIMatMelanoma.org).   ABOUT THE AIM AT MELANOMA FOUNDATION:…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “AIM at Melanoma Earns a Four-Star Rating From Charity Navigator”
12/23/2022

AIM at Melanoma Earns a Four-Star Rating From Charity Navigator

…AIM at Melanoma is dedicated to finding more effective treatments and, ultimately, the cure for melanoma while improving the lives…
Blog - Melanoma360
Philanthropy
Featured image for “Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients”
12/30/2024

Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients

…(brand name Yervoy), was approved for melanoma in 2011, and other immunotherapy approvals for melanoma followed in 2014 and 2015.…
Blog - Melanoma360
Breaking News

Tonia Sylvester: Why She Fights

…the medical team noticed a cluster of tiny little brown spots on her lower leg, which is referred to as…
Featured image for “Tonia Sylvester: Why She Fights”
Blog - Melanoma360
Survivor Stories

Interview with Allison Betof Warner, MD, PhD: TIL Therapy

…types of melanoma? Acral, mucosal, cutaneous, and melanoma of unknown primary origin are approved. These types of melanoma were included…
Featured image for “Interview with Allison Betof Warner, MD, PhD: TIL Therapy”
Blog - Melanoma360
Melanoma Research

In Plain English: Options for Stage III Melanoma

…III melanoma is considered high-risk—meaning it has a high likelihood of recurring or spreading. In fact, patients with Stage III…
Featured image for “In Plain English: Options for Stage III Melanoma”
Blog - Melanoma360
In Plain English

In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses

  By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
Featured image for “In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses”
Blog - Melanoma360
In Plain English

A Melanoma Story of Sisters, Love, and Healing

…her sister’s life interrupted, in 2010, Alice Googled “melanoma” and the results of the search turned up AIM at Melanoma’s…
Featured image for “A Melanoma Story of Sisters, Love, and Healing”
Blog - Melanoma360
Friends, Family, & Caregivers

USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

…treated metastatic melanoma; Checkmate 066–previously untreated metastatic melanoma; Checkmate 067–previously untreated metastatic melanoma, as a single agent or in combination…
Featured image for “USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma”
Blog - Melanoma360
Breaking News
Melanoma Research

President’s Letter | September 2022

…survivor stories: Please meet Erich Djordjevic and Bev Johnson. Erich is a Stage IV brain mets survivor, and Bev is…
Featured image for “President’s Letter | September 2022”
Blog - Melanoma360
President's Letter

AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center

…are welcome to query Alicia Rowell, Vice President, AIM at Melanoma Foundation (Alicia@AIMatMelanoma.org).   ABOUT THE AIM AT MELANOMA FOUNDATION:…
Featured image for “AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center”
Blog - Melanoma360
Breaking News
Melanoma Research

AIM at Melanoma Earns a Four-Star Rating From Charity Navigator

…AIM at Melanoma is dedicated to finding more effective treatments and, ultimately, the cure for melanoma while improving the lives…
Featured image for “AIM at Melanoma Earns a Four-Star Rating From Charity Navigator”
Blog - Melanoma360
Philanthropy

Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients

…(brand name Yervoy), was approved for melanoma in 2011, and other immunotherapy approvals for melanoma followed in 2014 and 2015.…
Featured image for “Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients”
Blog - Melanoma360
Breaking News